Aerocrine Signs Distribution Deal With Intramedic For Sweden

Solna (Sweden) and Copenhagen (Denmark) – December 18, 2013 – Aerocrine AB (OMX Nordic Exchange: AERO) today announces the signing of an exclusive agreement with Danish medical device company Intramedic AB for distribution of Aerocrine’s new airway inflammation monitor and test kit – NIOX VERO® – in Sweden. The agreement goes into effect on January 1, 2014 and gives Intramedic exclusive rights for the sales and distribution of Aerocrine’s new instrument NIOX VERO® and test kits, used for diagnosing and monitoring patients with asthma. The agreement also includes Intramedic taking on the support, sales and distribution for the already installed base of Aerocrine’s NIOX MINO® devices in the Swedish market.

Help employers find you! Check out all the jobs and post your resume.